Common side effects of filgotinib and how to deal with them correctly

Filgotinib is a selective Januskinase1 ( pan>JAK1) inhibitors are mainly used to treat moderately to severely active rheumatoid arthritis (RA) and other immune-inflammatory diseases. As a new oral targeted drug, filgotinib has attracted clinical attention in recent years due to its high selectivity and good efficacy. However, like all immunosuppressants, filgotinib may also have certain side effects during use. Understanding its common adverse reactions and correct countermeasures is crucial to patients' safe medication use and ensuring efficacy. This article will systematically introduce the common side effects of filgotinib and related treatment methods to help patients and medical staff manage risks during the treatment process.

1. Common side effects of filgotinib

1. Increased risk of infection: Because filgotinib suppresses the immune system, patients are prone to upper respiratory tract infections, urinary tract infections, herpes zoster and other opportunistic infections. Symptoms of infection include fever, cough, sore throat, abnormal urination, and skin blisters. Although serious infections are rare, a high level of vigilance is still required.

2.Hematological abnormalities: Some patients may have abnormal blood indicators such as leukopenia, anemia or thrombocytopenia. These changes are mostly mild to moderate and may occasionally lead to decreased immunity or an increased risk of bleeding.

3.Abnormal liver function: Figotinib can cause an increase in transaminases, manifested as an increase in ALT and AST levels, and some patients may develop jaundice or liver function damage.

4.Gastrointestinal discomfort: Patients may experience digestive system symptoms such as nausea, diarrhea, and abdominal pain, which are generally mild or moderate and can be relieved through symptomatic treatment.

5. Elevated blood lipids: During the treatment process, some patients’ serum cholesterol and triglyceride levels increase, which requires regular monitoring and management.

6.Other reactions: such as headache, fatigue, rash, etc., usually mild but need to be observed.

2. Correct measures to deal with side effects

1.Infection prevention and management

Users of filgotinib should avoid close contact with infected patients and pay attention to personal hygiene and cleanliness of the living environment. When symptoms such as fever, cough, difficulty breathing, or skin blisters occur, you should seek medical treatment promptly for infection screening and necessary anti-infective treatment. Doctors may suspend or adjust the dose of filgotinib according to the situation. In case of severe infection, the drug should be discontinued immediately and professional treatment should be provided. Vaccinations (such as pneumonia vaccine, influenza vaccine) can be completed before treatment, but live vaccines should be used with caution.

2.Monitoring and treatment of hematological abnormalities

Complete blood count monitoring should be performed regularly during treatment to detect abnormalities such as leukopenia or thrombocytopenia early. If a significant decrease is found, the doctor will adjust the dosage or temporarily stop the drug according to the situation. In severe cases, supportive treatment is required, such as blood transfusion or the use of drugs to stimulate bone marrow production. Patients should report any unusual bleeding, purpura, or signs of infection.

3.Liver function protection

Liver function indicators should be tested regularly before and during treatment with filgotinib, and changes in transaminases should be monitored. If liver function abnormalities are found, their severity should be assessed and the dose adjusted or discontinued if necessary. Avoid taking drugs and alcohol that are harmful to the liver at the same time to protect liver health.

4.Relief of gastrointestinal symptoms

When symptoms such as nausea and diarrhea occur, the discomfort can be relieved by adjusting the diet and taking antidiarrheal or anti-nausea drugs. If symptoms persist or worsen, you should seek medical treatment promptly to rule out other causes. Maintain adequate fluid intake to prevent dehydration.

5.Management of dyslipidemia

Blood lipid levels need to be monitored regularly during treatment. For patients with significantly elevated blood lipids, diet control, exercise, and the use of lipid-lowering drugs may be considered if necessary. Communicate closely with your doctor to rationally adjust the treatment plan to prevent an increase in cardiovascular risk.

6.Other symptoms and comprehensive management

When minor discomforts such as headaches and rashes occur, patients can treat them symptomatically while maintaining a good routine and mentality. If severe or persistent symptoms occur, the doctor should be notified in time for targeted treatment.

3. Daily precautions for patients

While using filgotinib, patients should strictly abide by the medication regimen instructed by their doctor and avoid stopping the medication or adjusting the dose on their own. Maintain regular outpatient review, and cooperate with testing of blood, liver function and infection-related indicators. Pay attention to rest, avoid fatigue, maintain balanced nutrition, and enhance body resistance. Avoid contact with sources of infection and report infections promptly. To avoid pregnancy while taking the medicine, women should take effective contraceptive measures.

Figotinib, as an effectiveJAK1 inhibitor, plays an important role in the treatment of rheumatoid arthritis and related diseases, but its immunosuppressive properties bring certain risks of side effects. Through scientific monitoring, early identification and timely treatment, the impact of adverse reactions on patients can be effectively reduced and the safety and effectiveness of treatment can be ensured. Close cooperation between patients and the medical team and maintaining good living habits are important guarantees for successful treatment. As the understanding of the side effects of filgotinib continues to deepen, it is expected to achieve more precise and personalized treatment in the future, improving patients' quality of life and treatment satisfaction.

Reference materials:https://www.drugs.com/